Summary & Overview
CPT 15792: Chemical Peel (Chemexfoliation)
CPT code 15792 designates a chemical peel (chemexfoliation), a dermatologic procedure that applies chemical agents to remove superficial scarring, sun damage, or acne by targeting the epidermis and, when required, the dermis. This code captures a commonly performed outpatient skin resurfacing service that spans medical and cosmetic indications and is relevant to dermatologists, plastic surgeons, and outpatient procedural practices nationwide. Nationally, chemical peels affect utilization patterns for office-based dermatology and ambulatory procedural settings, impacting payer coverage decisions and coding compliance.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context, service and site-of-service implications, and the typical billing environment for CPT code 15792. The publication highlights benchmarking and coverage themes, coding and documentation considerations for outpatient dermatologic procedures, and where to look for official policy updates. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 15792 describes a chemical peel (chemexfoliation), a dermatologic procedure that applies chemical agents such as alpha‑hydroxy acid, retinoic acid, or phenol to remove superficial scars, sun damage, or acne. The treatment targets the epidermis and may partially or completely involve it; involvement of the dermis depends on the agent used and duration of application.
Service Type: Dermatologic cosmetic/medical procedure — chemical exfoliation
Typical Site of Service: Outpatient dermatology clinic or physician office, including ambulatory surgery centers when deeper peels requiring procedural monitoring are performed.
Clinical & Coding Specifications
Clinical Context
A 34-year-old female presents to a dermatology clinic for evaluation of post-inflammatory hyperpigmentation and superficial acne scarring following resolution of moderate acne. After an initial consultation including medical history, skin assessment, and discussion of risks and benefits, the dermatologist determines that a medium-depth chemical peel is appropriate to address epidermal and superficial dermal changes. The patient consents and pre-procedure instructions are provided (discontinue topical retinoids 3–7 days prior, avoid recent isotretinoin within 6 months, arrange post-procedure wound care).
On the day of service, the procedure is performed in an ambulatory clinic procedure room. The provider applies topical anesthetic, isolates the treatment area, and applies the chemical agent in a controlled sequence to achieve the planned depth of exfoliation. The provider monitors patient comfort and skin response, documents start and stop times, agents used, percent concentrations, anatomic areas treated, and post-procedure instructions. Follow-up is scheduled for healing assessment and possible repeat treatments based on clinical response.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Normal, uncomplicated service | Use when the chemical peel was performed without complications and is the usual service provided by the practitioner |